Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000439875 | SCV000526899 | likely benign | not specified | 2016-05-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000730403 | SCV000858136 | uncertain significance | not provided | 2018-05-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083693 | SCV001129344 | likely benign | Citrin deficiency | 2024-10-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000730403 | SCV003823366 | uncertain significance | not provided | 2020-08-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003897892 | SCV004717265 | likely benign | SLC25A13-related disorder | 2021-05-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |